转录性可塑性驱动IMID和p300抑制剂在多发性骨髓瘤中的耐药性
Seongseok Yun1, John L Cleveland2
1Department of Malignant Hematology, Moffitt Cancer Center & Research Institute, Tampa, Florida.
Blood cancer discovery
|December 12, 2023
概括
研究人员发现了多发性髓瘤细胞如何对免疫调节药物 (IMiDs) 产生抗性. 这种耐药性涉及特定的蛋白质通路,这表明了治疗这种血液癌症的新组合疗法方法.
科学领域:
- 血液学 血液学 血液学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 免疫调节药物 (IMiDs) 在多发性骨髓瘤治疗中至关重要.
- 了解IMID耐药性的机制对于改善患者的治疗结果至关重要.
研究的目的:
- 阐明导致多发性骨髓瘤免疫调节药物 (IMiD) 耐药性的分子机制.
- 为了确定克服IMiD耐药性的潜在治疗目标.
主要方法:
- 有关RNA测序的RNA测序
- 染色体免疫沉降测序 (ChIP-seq) 是一种
- 使用测序 (ATAC-seq) 检测转化酶可访问的染色质.
- 遗传学研究 遗传学研究
主要成果:
- IMiD耐药性与MYC和IRF4的持续表达有关.
- 涉及ETV4和BATF蛋白质诱导的转录可塑性驱动抗性.
- 对超级增强剂的BRD4和p300招募是IMID耐药性的关键机制.
结论:
- 通过转录可塑性的持续MYC和IRF4表达是多发性骨髓瘤IMiD耐药性的基础.
- 与IMiDs和p300抑制剂的联合治疗显示出治疗耐药多发性骨髓瘤的前景.
相关概念视频
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Chromatin Modification in iPS Cells
1.7K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.7K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K


